Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Volumn 21, Issue 6, 2010, Pages 1021-1029

  Ahmed, Mohamed H ^a   Khalil, Atif A ^b  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZETIDINE DERIVATIVE; BIOLOGICAL MARKER; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DOWN REGULATION; DRUG COMBINATION; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; HUMAN; KIDNEY TRANSPLANTATION; REVIEW; TREATMENT OUTCOME;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DOWN-REGULATION; DRUG THERAPY, COMBINATION; DYSLIPIDEMIAS; EVIDENCE-BASED MEDICINE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; TREATMENT OUTCOME;

EID: 79952276880     PISSN: 13192442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)